Bernofarm is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1971. Bernofarm was established by Dr. Boenjamin Setiawan, a prominent figure in the Indonesian pharmaceutical industry. The company has grown to become one of Indonesia's leading pharmaceutical manufacturers, focusing on the production of high-quality generic medicines and over-the-counter products. Bernofarm's primary business line is the manufacturing of pharmaceutical products, with a secondary focus on research and development to innovate new drug formulations. The company operates several manufacturing facilities across Indonesia, ensuring a strong local presence and distribution network. The company's product portfolio includes a wide range of therapeutic categories such as antibiotics, analgesics, antihypertensives, and vitamins. Some of its well-known product brands include Bernofer, Bernozyme, and Bernoflox. Bernofarm has expanded its operations beyond Indonesia, exporting its products to several countries in Southeast Asia and Africa. The company is committed to maintaining high standards of quality and compliance with international regulations, which has helped it establish a reputable presence in the global market. Bernofarm collaborates with various international pharmaceutical companies and is a member of several industry associations, which helps it stay at the forefront of industry trends and innovations. The company's mission is to improve the quality of life by providing affordable and accessible healthcare solutions. Bernofarm envisions becoming a leading pharmaceutical company in the region, driven by innovation, quality, and customer satisfaction.
Headquarters
Rukan Puri Mansion Blok C No. 15
West Jakarta; Jakarta;
Postal Code: 11610
Contact Details: Purchase the PT Bernofarm report to view the information.
Website: http://www.bernofarm.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service